299 related articles for article (PubMed ID: 31344233)
1. Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement.
Olson J; Hersh AL; Sorensen J; Zobell J; Anderson C; Thorell EA
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):334-341. PubMed ID: 31344233
[TBL] [Abstract][Full Text] [Related]
2. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
3. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
Zhang X; Wu Y; Wang D
BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
[TBL] [Abstract][Full Text] [Related]
5. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.
Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J
Clin Pharmacol Ther; 2021 Jan; 109(1):212-221. PubMed ID: 33190285
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin is commonly under-dosed in critically ill children and neonates.
Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
[TBL] [Abstract][Full Text] [Related]
9. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
Joseph K; Ramireddy K; Madison G; Turco T; Lui M
J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
[TBL] [Abstract][Full Text] [Related]
11. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
[TBL] [Abstract][Full Text] [Related]
12. Impact of vancomycin therapeutic drug monitoring on patient care.
Welty TE; Copa AK
Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results.
Kim B; Hwang S; Heo E; Kim HS; Jung J; Kim ES; Kim HB; Lee K; Park JS; Song J; Lee JH; Chung JY; Song KH; Yoon S
J Korean Med Sci; 2023 Apr; 38(14):e101. PubMed ID: 37038640
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
[TBL] [Abstract][Full Text] [Related]
16. Area-Under-Curve-Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis.
Lim AS; Foo SHW; Benjamin Seng JJ; Magdeline Ng TT; Chng HT; Han Z
Ther Drug Monit; 2023 Aug; 45(4):519-532. PubMed ID: 36728329
[TBL] [Abstract][Full Text] [Related]
17. An Audit to Evaluate Vancomycin Therapeutic Drug Monitoring in a Neonatal Intensive Care Unit.
Alrahahleh D; Xu S; Zhu Z; Toufaili H; Luig M; Kim HY; Alffenaar JW
Ther Drug Monit; 2022 Oct; 44(5):651-658. PubMed ID: 35383737
[TBL] [Abstract][Full Text] [Related]
18. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin therapeutic drug monitoring in paediatrics.
Patel J; Lucas CJ; Ryan J; Jenkins M; Martin JH
J Paediatr Child Health; 2020 Apr; 56(4):563-570. PubMed ID: 31721353
[TBL] [Abstract][Full Text] [Related]
20. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
